Page 2089 - Hematology_ Basic Principles and Practice ( PDFDrive )

1856.e2 Part XII Hemostasis and Thrombosis

58. Anderson AO, Shaw S: T cell adhesion to endothelium: the FRC conduit 84. Grunewald M, Avraham I, Dor Y, et al: VEGF-induced adult neovas-
system and other anatomic and molecular features which facilitate the cularization: recruitment, retention, and role of accessory cells. Cell
adhesion cascade in lymph node. Semin Immunol 5:271, 1993. 124:175, 2006.
59. Lasky LA, Singer MS, Dowbenko D, et al: An endothelial ligand for 85. Rajantie I, Ilmonen M, Alminaite A, et al: Adult bone marrow-derived
L-selectin is a novel mucin-like molecule. Cell 69:927, 1992. cells recruited during angiogenesis comprise precursors for periendothe-
60. Kanda H, Tanaka T, Matsumoto M, et al: Endomucin, a sialomucin lial vascular mural cells. Blood 104:2084, 2004.
expressed in high endothelial venules, supports L-selectin-mediated 86. Dvorak HF, Brown LF, Detmar M, et al: Vascular permeability factor/
rolling. Int Immunol 16:1265, 2004. vascular endothelial growth factor, microvascular hyperpermeability, and
61. Umemoto E, Tanaka T, Kanda H, et al: Nepmucin, a novel HEV sialo- angiogenesis. Am J Pathol 146:1029, 1995.
mucin, mediates L-selectin-dependent lymphocyte rolling and promotes 87. Hanahan D, Folkman J: Patterns and emerging mechanisms of the
lymphocyte adhesion under flow. J Exp Med 203:1306, 2006. angiogenic switch during tumorigenesis. Cell 86:353, 1996.
62. Girard JP, Baekkevold ES, Yamanaka T, et al: Heterogeneity of endothe- 88. Conway EM, Collen D, Carmeliet P: Molecular mechanisms of blood
lial cells: the specialized phenotype of human high endothelial venules vessel growth. Cardiovasc Res 49:507, 2001.
characterized by suppression subtractive hybridization. Am J Pathol 89. Gerhardt H, Golding M, Fruttiger M, et al: VEGF guides angiogenic
155:2043, 1999. sprouting utilizing endothelial tip cell filopodia. J Cell Biol 161:1163,
63. Rosemblatt M, Bono MR: Functional consequences of immune cell 2003.
adhesion to endothelial cells. Curr Pharm Des 10:109, 2004. 90. Kamei M, Saunders WB, Bayless KJ, et al: Endothelial tubes assemble
64. Tavassoli M: Hemopoietic endothelium, incognito. Exp Hematol 20:386, from intracellular vacuoles in vivo. Nature 442:453, 2006.
1992. 91. Davis GE, Senger DR: Endothelial extracellular matrix: biosynthesis,
65. Wilson JG, Tavassoli M: Microenvironmental factors involved in the remodeling, and functions during vascular morphogenesis and neovessel
establishment of erythropoiesis in bone marrow. Ann NY Acad Sci stabilization. Circ Res 97:1093, 2005.
718:27, 1994. 92. Djonov VG, Kurz H, Burri PH: Optimality in the developing vascular
66. Mohle R, Bautz F, Rafii S, et al: The chemokine receptor CXCR-4 system: branching remodeling by means of intussusception as an efficient
is expressed on CD34+ hematopoietic progenitors and leukemic cells adaptation mechanism. Dev Dyn 224:391, 2002.
and mediates transendothelial migration induced by stromal cell-derived 93. DeRuiter MC, Poelmann RE, VanMunsteren JC, et al: Embryonic
factor-1. Blood 91:4523, 1998. endothelial cells transdifferentiate into mesenchymal cells expressing
67. Lapidot T, Dar A, Kollet O: How do stem cells find their way home? smooth muscle actins in vivo and in vitro. Circ Res 80:444, 1997.
Blood 106:1901, 2005. 94. High FA, Zhang M, Proweller A, et al: An essential role for Notch
68. Papayannopoulou T, Priestley GV, Nakamoto B, et al: Molecular path- in neural crest during cardiovascular development and smooth muscle
ways in bone marrow homing: dominant role of alpha(4)beta(1) over differentiation. J Clin Invest 117:353, 2007.
beta(2)-integrins and selectins. Blood 98:2403, 2001. 95. De Palma M, Venneri MA, Galli R, et al: Tie2 identifies a hematopoietic
69. Frenette PS, Subbarao S, Mazo IB, et al: Endothelial selectins and lineage of proangiogenic monocytes required for tumor vessel formation
vascular cell adhesion molecule-1 promote hematopoietic progenitor and a mesenchymal population of pericyte progenitors. Cancer Cell
homing to bone marrow. Proc Natl Acad Sci USA 95:14423, 1998. 8:211, 2005.
70. Langman J: Medical embryology, (vol 4). Baltimore, 1981, Williams & 96. Song S, Ewald AJ, Stallcup W, et al: PDGFRbeta+ perivascular progeni-
Wilkins. tor cells in tumours regulate pericyte differentiation and vascular survival.
71. McDonald DM, Foss AJ: Endothelial cells of tumor vessels: abnormal Nat Cell Biol 7:870, 2005.
but not absent. Cancer Metastasis Rev 19:109, 2000. 97. Yamada Y, Takakura N: Physiological pathway of differentiation of
72. Eichmann A, Pardanaud L, Yuan L, et al: Vasculogenesis and the search hematopoietic stem cell population into mural cells. J Exp Med 203:1055,
for the hemangioblast. J Hematother Stem Cell Res 11:207, 2002. 2006.
73. Dieterlen-Lievre F, Godin I, Pardanaud L: Where do hematopoietic stem 98. Bergers G, Song S, Meyer-Morse N, et al: Benefits of targeting both
cells come from? Int Arch Allergy Immunol 112:3, 1997. pericytes and endothelial cells in the tumor vasculature with kinase
74. Asahara T, Murohara T, Sullivan A, et al: Isolation of putative progenitor inhibitors. J Clin Invest 111:1287, 2003.
endothelial cells for angiogenesis. Science 275:964, 1997. 99. Xian X, Hakansson J, Stahlberg A, et al: Pericytes limit tumor cell
75. Grant MB, May WS, Caballero S, et al: Adult hematopoietic stem cells metastasis. J Clin Invest 116:642, 2006.
provide functional hemangioblast activity during retinal neovasculariza- 100. Baluk P, Morikawa S, Haskell A, et al: Abnormalities of basement
tion. Nat Med 8:607, 2002. membrane on blood vessels and endothelial sprouts in tumors. Am J
76. Jiang Y, Jahagirdar BN, Reinhardt RL, et al: Pluripotency of mesenchy- Pathol 163:1801, 2003.
mal stem cells derived from adult marrow. Nature 418:41, 2002. 101. van Hinsbergh VW, Engelse MA, Quax PH: Pericellular proteases in
77. Reyes M, Dudek A, Jahagirdar B, et al: Origin of endothelial progenitors angiogenesis and vasculogenesis. Arterioscler Thromb Vasc Biol 26:716,
in human postnatal bone marrow. J Clin Invest 109:337, 2002. 2006.
78. Matsumura G, Miyagawa-Tomita S, Shin’oka T, et al: First evidence that 102. Vlodavsky I, Abboud-Jarrous G, Elkin M, et al: The impact of hepa-
bone marrow cells contribute to the construction of tissue-engineered ranese and heparin on cancer metastasis and angiogenesis. Pathophysiol
vascular autografts in vivo. Circulation 108:1729, 2003. Haemost Thromb 35:116, 2006.
79. Rafii S, Lyden D, Benezra R, et al: Vascular and haematopoietic stem 103. Chirco R, Liu XW, Jung KK, et al: Novel functions of TIMPs in cell
cells: novel targets for anti-angiogenesis therapy? Nat Rev Cancer 2:826, signaling. Cancer Metastasis Rev 25:99, 2006.
2002. 104. Hynes RO: A reevaluation of integrins as regulators of angiogenesis.
80. Heissig B, Hattori K, Dias M, et al: Recruitment of stem and progenitor Nat Med 8:918, 2002.
cells from the bone marrow niche requires MMP-9 mediated release of 105. Stupack DG, Cheresh DA: ECM remodeling regulates angiogen-
kit-ligand. Cell 109:625, 2002. esis: endothelial integrins look for new ligands. Sci STKE 2002:E7,
81. Hattori K, Heissig B, Tashiro K, et al: Plasma elevation of stromal 2002.
cell-derived factor-1 induces mobilization of mature and immature 106. Stupack DG, Cheresh DA: Get a ligand, get a life: Integrins, signaling
hematopoietic progenitor and stem cells. Blood 97:3354, 2001. and cell survival. J Cell Sci 115:3729, 2002.
82. Laterveer L, Lindley J, Hamilton MS, et al: Interleukin-8 induces rapid 107. Cai W, Chen X: Anti-angiogenic cancer therapy based on integrin
mobilization of hematopoietic stem cells with radioprotective capacity alphavbeta3 antagonism. Anticancer Agents Med Chem 6:407,
and long term myelolymphoid repopulating ability. Blood 85:2269, 2006.
1995. 108. Alghisi GC, Ruegg C: Vascular integrins in tumor angiogenesis: media-
83. De Palma M, Naldini L: Role of haematopoietic cells and endothelial tors and therapeutic targets. Endothelium 13:113, 2006.
progenitors in tumour angiogenesis. Biochim Biophys Acta 1766:159, 109. Leong KG, Hu X, Li L, et al: Activated Notch4 inhibits angiogenesis:
2006. role of beta 1-integrin activation. Mol Cell Biol 22:2830, 2002.